Sepsis, the leading cause of death in U.S. hospitals killing about 350,000 people annually, is an extreme response to an ...
Using a simple blood draw, the TriVerity system spits out three scores to ER personnel within 30 minutes that determine if ...
The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...
J&J on Tuesday said the green light makes Spravato the first and only monotherapy for adults with major depressive disorder who have had an inadequate response to at least two oral antidepressants.
Red 40 is making headlines again as lawmakers debate whether food dyes should be banned in the US. Here's what health experts say about its safety.
Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to the pharmaceutical company. The nasal spray can be given to people who haven’t seen improvements ...
Kentuckians can't get mifepristone to treat miscarriages because of state anti-abortion law, FDA regulation and confusion ...